Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘regenerative medicine’ Category

Case report of stem cell therapy in child didn’t meet “ethical standards,” says journal

without comments

A journal has retracted a recent case report about a stem cell therapy in a child with cerebral palsy, after discovering the study failed to meet “ethical standards.”

According to the journal, Regenerative Medicine, the ethical issue is that the authors failed to report the case to the Ministry of Health, Labor and Welfare of Japan, which violates the country’s guidelines for conducting stem cell research. Unfortunately, we don’t know much more than that about what happened.

Laura Dormer, editorial director of Future Science Group, which publishes Regenerative Medicine, explained that the paper’s first author, Masato Kantake, requested the retraction because: Read the rest of this entry »

Biotech company retracts Parkinson’s treatment study after “possible deviation from protocol”

with 6 comments

LCTLiving Cell Technologies (LCT), a biotech company headquartered in Australia, has retracted a 2011 paper purporting to show that their product reversed Parkinson’s symptoms in rats after “being unable to reconfirm their reported results and a possible deviation from the protocol.”

LCT is developing NTCELL, which, according to their site: Read the rest of this entry »